BioSyent Inc. (OTCMKTS:BIOYF) Sees Large Increase in Short Interest

BioSyent Inc. (OTCMKTS:BIOYF) saw a large growth in short interest in the month of September. As of September 30th, there was short interest totalling 1,900 shares, a growth of 58.3% from the September 15th total of 1,200 shares. Based on an average trading volume of 1,600 shares, the short-interest ratio is presently 1.2 days.

BioSyent Price Performance

Shares of BioSyent stock remained flat at $7.75 during trading on Monday. BioSyent has a 12-month low of $5.65 and a 12-month high of $8.90. The company’s 50-day simple moving average is $7.79 and its two-hundred day simple moving average is $7.15.

BioSyent Increases Dividend

The firm also recently announced a dividend, which was paid on Sunday, September 15th. Stockholders of record on Thursday, September 5th were paid a $0.0334 dividend. This represents a dividend yield of 1.72%. The ex-dividend date of this dividend was Wednesday, September 4th. This is a positive change from BioSyent’s previous dividend of $0.03.

About BioSyent

BioSyent Inc, together with its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia.